Home › Funds › PERCEPTIVE ADVISORS LLC › IONS

PERCEPTIVE ADVISORS LLC position in IONS

IONIS PHARMACEUTICALS INC · Health Care

PERCEPTIVE ADVISORS LLC reported holding 566,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$44.9M, representing 0.71% of its reported portfolio and ranking #31 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed IONS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)566.00K sh
Reported value held$44.88M
Portfolio Weight0.71%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PERCEPTIVE ADVISORS LLC's IONS position evolved

PERCEPTIVE ADVISORS LLC first disclosed a stake in IONS in Q1 2026 at 504,000 shares (US$37.8M). The position peaked in Q2 2026 at 566,000 shares, worth US$44.9M. Across 2 filings, PERCEPTIVE ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 566,000 shares valued at US$44.9M — an increase of 62,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 504.00K $37.85M New
Q2 2026 566.00K $44.88M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has PERCEPTIVE ADVISORS LLC held IONS?

PERCEPTIVE ADVISORS LLC has disclosed IONS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is PERCEPTIVE ADVISORS LLC's current position in IONS?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 566.00K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $44.88M, representing 0.71% of its reported portfolio and ranking #31.

Has PERCEPTIVE ADVISORS LLC been buying or selling IONS?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in IONS. The position peaked in Q2 2026 at 566.00K shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.